Carter has previously been responsible for increasing retail sales and negotiating new sales opportunities for a number of international pharmacy companies including AAH Pharmaceuticals and Mylan. She has also worked as a prescribing technician for Central Cheshire Primary Care Group.
The company says Carter’s industry credentials and experience of working in both hospital and retail pharmacy will enable the firm to extend its partnerships with hospitals and dispensing doctors.
Quantum appoints national account manager
Pauline Carter brings 18 years’ experience to the role
You may also like
Finance
European life sciences investors kick off 2026 with targeted bets on immunity, oncology and metabolic health
From thymus regeneration and ECM-targeted oncology to fast-scaling metabolic health technology, three European companies secure fresh capital as investors double down on differentiated science with clear commercial momentum
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Research & Development
Biologics at a turning point: complexity, AI and the road to 2026
Despite rapid change, the growing complexity of biologics and the rise of AI-driven design are reinforcing the increasing need for deep scientific expertise and innovation leadership, says Campbell Bunce (CB), Chief Scientific Officer at Abzena
Manufacturing
ITT to acquire SPX FLOW in $4.8bn deal, expanding global leadership in engineered components and flow technologies
Acquisition strengthens ITT’s position in industrial, chemical, energy, health and nutrition markets, adding high-margin revenue, major aftermarket growth and $80m in expected synergies by year three
Finance
EIB and Angelini Ventures launch €150m fund to boost European biotech, medtech and digital health startups
The EIB and Angelini Ventures will co-invest €150 million to scale innovative European healthtech companies. The deal marks the EIB’s first partnership with a corporate venture capital fund in the healthcare sector